Amgen at ESMO: IMDELLTRA data points to earlier lung cancer use

🌐 Investing.com (Cyprus) —
Amgen at ESMO: IMDELLTRA data points to earlier lung cancer use

AI Summary

Amgen presented clinical data on IMDELLTRA at the European Society for Medical Oncology meeting, pointing to potential use earlier in the treatment of lung cancer. The provided article contains no further details about the results.

Markets Health Amgen IMDELLTRA lung cancer oncology clinical data ESMO

Read original source →